Skip to main content

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Liabilities (QFRTL385USNO)

Observation:

Q3 2024: 1,133,630 (+ more)  Updated: Dec 10, 2024 9:07 AM CST
Q3 2024:  1,133,630  
Q2 2024:  1,131,421  
Q1 2024:  1,133,642  
Q4 2023:  1,120,625  
Q3 2023:  1,050,516  

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

NOTES

Title Release Dates
Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Total Liabilities 2017-09-06 2024-12-10
 
Source    
U.S. Census Bureau 2017-09-06 2024-12-10
 
Release    
Quarterly Financial Report 2017-09-06 2024-12-10
 
Units    
Millions of Dollars 2017-09-06 2024-12-10
 
Frequency    
Quarterly 2017-09-06 2024-12-10
 
Seasonal Adjustment    
Not Seasonally Adjusted 2017-09-06 2024-12-10
 
Notes    
Further information related to the Quarterly Financial Report survey can be found at https://www.census.gov/econ/qfr/about.html
Methodology details can be found at https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf

2017-09-06 2024-12-10

RELEASE TABLES

Quarterly Financial Report

RELATED DATA AND CONTENT

Data Suggestions Based On Your Search

Content Suggestions

Related Categories

Financial Activity Measures Financial Indicators Money, Banking, & Finance

Releases

More Series from Quarterly Financial Report

Tags

Medicines Pharmaceuticals Quarterly Financial Report Chemicals Finance Nondurable Goods Liabilities Corporate Goods Manufacturing Industry Quarterly Census Nation Public Domain: Citation Requested Not Seasonally Adjusted United States of America